Today, Matt and Erin talk about EPA's review of a popular neonic called imidacloprid. This and other active neonic ingredients have been blamed for declines in honey bee health. They share their thoughts on implications for cancellation, bee health and non-target insects.
It's the first podcasting episode of 2017! Matt and Erin talk briefly about a few topics related to insecticides today. First, Erin recaps the findings of her insecticide resistance project from 2016. A field sprayed twice with a pyrethroid (bifenthrin) did not have efficacy against soybean aphid. She conducted an assay and discovered elevated resistance ratios for bifenthrin and lambda-cyhalothrin. Distinguishing insecticide group will become important for future growing seasons so farmers can prolong the efficacy of pyrethroids and organophosphates. Learn more about insecticide groups and resistance management at the IRAC website. Matt shared updates on pending EPA approvals of existing insecticides. Chlorpyrifos, an organophosphate, had an open comment period that closed January 17, 2017; read more about the health risk assessment for chlorpyrifos. In addition, the EPA has four public comment dockets open now regarding pollinator-only risk assessments for the neonicotinoid insecticides clothianidin, thiamethoxam, and dinotefuran.
Erin and Matt are speaking at the ISU Crop Advantage Series this month. Find locations and registration details here. Erin is also speaking on a resistance management panel at the 2017 Iowa Soybean Research Conference on February 8, 2017.
Watch an IRAC video on how insecticide resistance happens!